Literature DB >> 19691867

Schistosomiasis--a rich vein of research.

Paul Hagan1.   

Abstract

The expansion in the volume of research activity over the last 100 years and the acceleration of technological change that underpins the nature and, to a lesser extent, the quality of the science we do, means that those in science today have little time, or indeed opportunity, for reflection on some of the pioneering efforts within their fields. From the first discovery of schistosome parasites in Egypt in 1851 by Theodor Bilharz, research on schistosomiasis has provided valuable insights into many wider aspects of biology and medicine and has attracted an array of colourful and dynamic scientists who have made major advances through elegant experimentation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691867     DOI: 10.1017/S003118200999093X

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  4 in total

Review 1.  Schistosomiasis vaccines.

Authors:  Afzal A Siddiqui; Bilal A Siddiqui; Lisa Ganley-Leal
Journal:  Hum Vaccin       Date:  2011-11-01

2.  Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis.

Authors:  C Lochmatter; C L Schneider; K Ingram; J Keiser; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

3.  IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.

Authors:  Mark S Wilson; Allen W Cheever; Sandra D White; Robert W Thompson; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

4.  Inside Doctor Livingstone: a Scottish icon's encounter with tropical disease.

Authors:  Michael P Barrett; Federica Giordani
Journal:  Parasitology       Date:  2016-12-08       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.